CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 424,035	$ 205,156
Interest bearing deposits with banks	306,885	1,844,764
Investment securities:
Equity securities	35,992	36,473
Trading debt securities	11,739	38,130
Available for sale debt securities	1,015,034	1,128,809
Held to maturity debt securities (net of allowance for credit losses of $1,222 at March 31, 2022 and $1,165 at December 31, 2021)	3,071,983	2,667,532
Total investment securities	4,134,748	3,870,944
Loans held for sale, at fair value	77,632	139,516
Loans	35,364,405	34,153,657
Less: Allowance for loan losses	(362,510)	(359,202)
Net loans	35,001,895	33,794,455
Premises and equipment, net	337,479	326,306
Lease right of use assets	258,512	259,117
Bank owned life insurance	566,440	566,770
Accrued interest receivable	102,667	96,882
Goodwill	1,468,354	1,459,008
Other intangible assets, net	74,884	70,386
Other assets	797,926	813,139
Total Assets	43,551,457	43,446,443
Deposits:
Non-interest bearing	11,947,001	11,675,748
Interest bearing:
Savings, NOW and money market	20,285,967	20,269,620
Time	3,414,368	3,687,044
Total deposits	35,647,336	35,632,412
Short-term borrowings	484,181	655,726
Long-term borrowings	1,409,142	1,423,676
Junior subordinated debentures issued to capital trusts	56,500	56,413
Lease liabilities	282,437	283,106
Accrued expenses and other liabilities	575,477	311,044
Total Liabilities	38,455,073	38,362,377
Shareholders’ Equity
Common stock (no par value, authorized 650,000,000 shares; issued 423,034,027 shares at March 31, 2022 and December 31, 2021)	148,482	148,482
Surplus	3,872,236	3,883,035
Retained earnings	945,225	883,645
Accumulated other comprehensive loss	(56,098)	(17,932)
Treasury stock, at cost (1,639,750 common shares at March 31, 2022 and 1,596,959 common shares at December 31, 2021)	(23,152)	(22,855)
Total Shareholders’ Equity	5,096,384	5,084,066
Total Liabilities and Shareholders’ Equity	43,551,457	43,446,443
Series A
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	111,590	111,590
Series B
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	$ 98,101	$ 98,101